Clonidine Plus GHRH Administration for Diagnosing Growth Hormone Deficiency in Children

Journal Title: Journal of Clinical and Molecular Endocrinology - Year 2017, Vol 2, Issue 1

Abstract

Objective: To analyze the effectiveness and reproductivity of a challenge with clonidine (CLO) plus GHRH administration to establish a state of GH-deficiency and the causes of it. Methods: 24 children (17M, 7F) with stature <1 or 2 SD from P3, previously studied with different classical tests, were given CLO (150 μg/m2 orally, at time 0’) plus GHRH (60’ later, 1 μg/kg, iv). This test was repeated but giving placebo at time 0’. For comparison purposes, 20 agematched normal children (14M, 6F) were studied. Growth velocity (GV) and bone age (BA) before performing CLO +GHRH were considered. Results: While classical GH tests show a great variability of negative or positive GH responses in the same short patient, all but two patients significantly responded to CLO+GHRH (GH peak: 42.2 ± 19 vs. 41.6 ± 3.5 in controls). Controls showed a significant positive correlation between the amplitude of GH response and chronological and bone age (R=0.832; F=37.6; P=0.001, multiple regression analysis): y=a+b × BA+c × CA, where y=GH peak, BA=bone age, CA=chronological age, and a, b and c are constants. This equation allows to establish the value of GH peak theoretically obtained after CLO+GHRH challenge in a normal child. Applying this equation to the responses to CLO+GHRH in short children a deviation, ranging between -435% and +41%, was obtained between theoretical and real GH peaks (%DT-R). Responses between -20% to +20% were considered normal. Plotting these responses (% DT-R) against the SD of the mean of the BA to GV ratio in normal children, five populations were defined: 1) Low response and low GV for BA; 2) Low response and normal GV for BA; 3) Normal response and low GV for BA; 4) Normal response and normal GV for BA; and 5) High response and low GV for BA.

Authors and Affiliations

Jesús Devesa

Keywords

Related Articles

False Positive TSH Receptor Binding Inhibitory Immunoglobulin in a Patient with Overt Hyperthyroidism Caused by Painless Thyroiditis

The diagnosis of Graves’s disease (GD) can be challenging in patients with atypical presentations of hyperthyroidism. Recently, TSH receptor antibody assays are proposed as first-line test for suspected GD. I here report...

A Descriptive Study on Children with Congenital Adrenal Hyperplasia Attending Assiut University Children Hospital

Introduction: Congenital adrenal hyperplasia is a group of autosomal recessive disorders that result from the deficiency of one of several enzymes involved in the steroidogenic pathway for cortisol biosynthesis. The most...

The Other Legacy of Antonie Van Leeuwenhoek: The Polyamines

Antonie van Leeuwenhoek (1632-1723) left us two legacies; the first is the microscope and the second, the discovering of polyamines in the human semen.

Ketotifen and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus

Objective: Mast cells found to be an important contributor to inflammation, obesity, diabetes and atherosclerosis. We evaluate the ability of ketotifen to reduce cardiovascular risk in patient with type 2 diabetes millet...

Antidiabetics and Heart Failure - Large Trials but Little Mechanistic Insight

Glucose lowering efficacy was the basis for the approval of antihyperglycaemic drug in the past. However, increasing concerns emerged about potential cardiovascular side effects of these drugs following the metaanalysis...

Download PDF file
  • EP ID EP305797
  • DOI 10.21767/2572-5432.100042
  • Views 51
  • Downloads 0

How To Cite

Jesús Devesa (2017). Clonidine Plus GHRH Administration for Diagnosing Growth Hormone Deficiency in Children. Journal of Clinical and Molecular Endocrinology, 2(1), 1-7. https://europub.co.uk/articles/-A-305797